PATENT CLAIM ANALYSIS

Application Number: 16261353
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds as inhibitor of WNT signal transduction pathway, as well as a composition comprising the same. Further, the present invention relates to the use of the compounds in the treatment of cancer.

Claim (Index 8):
The method of  claim 1 , wherein the cancer is colorectal cancer, gastric cancer, liver cancer, or esophageal cancer.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15617988', '14772337', '15650494', '14772334', '14408254']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8398691420346279
- 35 USC 102 Novelty (BERT): 0.7203744774441667
- Combined Prediction Score: 0.8279196755755818
- Mean Citation Score: 572.2020719999998
- Max Citation Score: 821.2218
- Similarity Product: 766.2154792206285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test